The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived
Circulation · 2023
DOI: 10.1161/circulationaha.123.066510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, 2023. Verfasst von Paul M Ridker. Beteiligte Einrichtung: Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospit…. Hauptthemen laut MEDLINE: Coronary Artery Disease, Atherosclerosis. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cardiovascular Disease Prevention, Division of Preventive Medicine and the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.
ORCID-Profile: Paul M Ridker
Zitieren
APA
Ridker, P. M. (2023). The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived. Circulation. https://doi.org/10.1161/circulationaha.123.066510
Vancouver
Ridker PM. The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived. Circulation. 2023. doi:10.1161/circulationaha.123.066510
BibTeX
@article{Ridker2023,
author = {Ridker, Paul M},
title = {The Time to Initiate Anti-Inflammatory Therapy for Patients With Chronic Coronary Atherosclerosis Has Arrived},
journal = {Circulation},
year = {2023},
doi = {10.1161/circulationaha.123.066510}
}
EUVIMED